Gastrointestinal Over-The-Counter (OTC) Drugs Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Japan, Germany, France - Size and Forecast 2024-2028

Gastrointestinal Over-The-Counter Drugs Market Size 2024-2028

The gastrointestinal over-the-counter drugs market size is forecast to increase by USD 5.27 billion at a CAGR of 5.55% between 2023 and 2028.

• The market is witnessing significant growth due to several key factors. The prevalence of gastrointestinal disorders is on the rise, leading to an increase in demand for generic drugs to manage symptoms. Additionally, the adoption of online platforms for purchasing OTC drugs is growing, making it more convenient for consumers to access these medications.
• However, there is a risk associated with self-diagnosis and taking incorrect medication. This trend is a challenge for the market, as it may lead to adverse health effects and potential misuse of OTC drugs. Overall, the market for gastrointestinal OTC drugs is expected to grow steadily, driven by these factors and the increasing awareness of self-care and health management.

What will be the Size of the Gastrointestinal Over-The-Counter Drugs Market During the Forecast Period?

Request Free Sample

• The market encompasses a range of products designed to manage various conditions, including nausea, diarrhea, heartburn, indigestion, and constipation. These non-prescription remedies cater to individuals seeking effective treatments for stomach upsets and gastrointestinal issues without the need for a doctor's prescription.
• OTC offerings include antacids, probiotics, health supplements, and liquid tablets, among others. Market trends reflect a growing emphasis on natural drugs and improving health, with an increasing number of collaborations between research institutions and industry players to develop innovative solutions. Preventing conditions such as motion sickness and constipation, as well as managing chronic issues like GERD and cardiovascular disease, are key priorities.
• Effective treatments for these conditions can help reduce emergency room visits, misdiagnosis, and cognitive decline associated with untreated gastrointestinal issues. The OTC market's growth is driven by the availability of a wide range of products, accessibility, and affordability, making it an essential component of international healthcare infrastructure and medical care.

How is this Gastrointestinal OTC Drugs Industry segmented and which is the largest segment?

The gastrointestinal over-the-counter drugs industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Product
  • Antacid
  • Laxatives
  • Anti-diarrheal
  • Anti-emetics
  • Others
• Distribution Channel
  • Offline
  • Online
• Geography
  • North America
    • US
  • Europe
    • Germany
    • France
  • Asia
    • China
    • Japan
  • Rest of World (ROW)

By Product Insights

• The antacid segment is estimated to witness significant growth during the forecast period.

The gastrointestinal over-the-counter (OTC) drug market encompasses a range of formulations designed to address various disorders. Antacids, a significant segment, alleviate symptoms of acid reflux, indigestion, and heartburn by neutralizing stomach acid. Prevalence of gastrointestinal disorders, fueled by unhealthy diets, stress, and NSAID use, drives antacid demand. Forms include tablets, capsules, suspensions, and chewables. Other gastrointestinal OTC drugs treat conditions like diarrhea, constipation, and gastroesophageal reflux disease (GERD). Consumer awareness, healthcare access, and changing lifestyles have increased the demand for these accessible treatments. Antiemetics, laxatives, and probiotic-based drugs are also integral to the market. Health-conscious consumers seek advanced healthcare infrastructure for effective treatments, driving growth. OTC drugs cater to various gastrointestinal disorders, offering relief and convenience.

Get a glance at the Gastrointestinal Over-The-Counter (OTC) Drugs Industry report of share of various segments Request Free Sample

The Antacid segment was valued at USD 6.73 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

• North America is estimated to contribute 44% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The North American market holds a substantial share In the global over-the-counter (OTC) drugs market for gastrointestinal disorders. Factors such as sedentary lifestyles, unhealthy diets, and increasing stress levels are fueling the demand for OTC medications in this region. These issues contribute to common gastrointestinal problems, including irritable bowel syndrome (IBS), constipation, diarrhea, and heartburn. Furthermore, the aging population in North America is a significant contributor to the market's growth. As people age, they become more susceptible to gastrointestinal disorders. Consequently, OTC drugs for gastrointestinal issues are increasingly sought after for their accessibility and affordability. Consumer awareness and healthcare infrastructure advancements have made these treatments more accessible through retail pharmacies and hospitals.

Common gastrointestinal OTC drugs include antacids, laxatives, and anti-emetics. Additionally, probiotic-based drugs are gaining popularity due to their natural benefits. The market's growth is further driven by health-conscious consumers seeking accessible treatments for their gastrointestinal disorders. Key gastrointestinal disorders addressed by OTC drugs include gastroesophageal reflux disease (GERD), diarrhea, and vomiting. As healthcare entities continue to expand their offerings, collaborations and direct tenders are expected to influence market growth. Despite incorrect diagnoses and potential complications, OTC drugs offer a convenient and cost-effective solution for many individuals dealing with gastrointestinal disorders.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise In the adoption of Gastrointestinal Over-The-Counter (OTC) Drugs Industry?

Increase in prevalence of gastrointestinal disorders is the key driver of the market.

• Gastrointestinal disorders, encompassing conditions that impact the digestive system, have seen a notable rise in prevalence globally. This trend is attributed to altering lifestyles and dietary habits, with the consumption of processed and fast food becoming increasingly prevalent. Consequently, disorders such as indigestion, heartburn, diarrhea, and vomiting have become common health concerns. Over-the-counter (OTC) drugs have emerged as accessible treatments for these conditions, with formulations including liquid, chewable tablets, and probiotic-based drugs, such as antacids and anti-emetics, being popular choices. Consumer awareness regarding self-medication for gastrointestinal disorders has grown, leading to an increase in retail pharmacy sales. However, incorrect diagnosis and the potential for incorrect use of OTC drugs pose risks, necessitating expert analysis and proper healthcare access.
• The gastrointestinal disorders market is expected to grow, driven by patient epidemiology, changing lifestyles, and advanced healthcare infrastructure. Collaborations between healthcare entities and pharmaceutical companies are also contributing to the development of new treatments for gastrointestinal disorders, including laxatives for constipation and advanced formulations for gastroesophageal reflux disease (GERD) and diarrhea. Despite these advancements, challenges persist, including patent expiry, drug abuse, and infrastructure development, particularly in underdeveloped healthcare systems. The OTC drugs market offers accessible treatments for a wide range of gastrointestinal disorders, providing relief for millions of people worldwide.

What are the market trends shaping the Gastrointestinal Over-The-Counter (OTC) Drugs Industry?

Increase in adoption of online platforms for gastrointestinal OTC drugs is the upcoming market trend.

• The market In the US has experienced notable growth due to the increasing consumer awareness and changing lifestyles. This market encompasses a wide range of formulations, including chewable tablets, liquids, and probiotic-based drugs, designed to address various gastrointestinal disorders such as heartburn, indigestion, diarrhea, and constipation. The convenience and accessibility offered by retail pharmacies and online platforms have contributed significantly to the market's expansion. Consumers can easily access these treatments without a prescription, making them an attractive option for self-medication. Furthermore, the availability of advanced healthcare infrastructure and collaborations between healthcare entities have led to the development of more accessible treatments for gastrointestinal disorders.
• The market caters to various patient populations, including those suffering from gastroesophageal reflux disease (GERD), diarrhea, vomiting, and nausea. Antacids, anti-emetics, laxatives, and other gastrointestinal products are popular choices for treating these conditions. Patients with more complex conditions, such as kidney failure, cancer, and memory loss, may require prescription drugs, but OTC drugs remain a significant part of their healthcare needs. Despite the benefits, incorrect diagnosis and drug abuse pose challenges to the market. Patients must consult healthcare professionals for proper diagnosis and dosage instructions to avoid potential complications. Additionally, healthcare infrastructure plays a crucial role in ensuring the availability and affordability of these treatments, especially in underserved communities.
• In conclusion, the gastrointestinal OTC drugs market is driven by consumer awareness, changing lifestyles, and the availability of accessible treatments. The market offers a diverse range of options for addressing various gastrointestinal disorders, making it an essential component of the overall healthcare landscape.

What challenges does the Gastrointestinal Over-The-Counter (OTC) Drugs Industry face during its growth?

Risk of taking wrong medication due to incorrect self-diagnosis is a key challenge affecting the industry growth.

• The over-the-counter (OTC) market for gastrointestinal (GI) drugs In the US has witnessed significant growth due to the increasing consumer awareness and accessibility of treatments for common GI disorders such as heartburn, indigestion, diarrhea, and constipation. Liquid formulations and chewable tablets have gained popularity among consumers, particularly for conditions like diarrhea and nausea. However, the availability of these OTC medications without the need for a prescription has raised concerns over incorrect self-diagnosis and subsequent use of inappropriate treatments. Patients may mistake symptoms of various GI disorders and opt for incorrect OTC drugs, leading to potential side effects, prolonged discomfort, and even more serious complications.
• This highlights the importance of proper consumer education and consultation with healthcare professionals before self-medicating. The healthcare infrastructure, including retail pharmacies and hospital pharmacies, plays a crucial role in providing accessible treatments for patients. The pharmaceutical industry continues to innovate, with the development of advanced healthcare infrastructure, natural remedies, and probiotic-based drugs. The patient epidemiology for GI disorders, including gastroesophageal reflux disease (GERD), continues to grow, fueling the demand for OTC drugs. Despite these advancements, challenges such as incorrect diagnosis, drug abuse, and patent expiry persist, necessitating ongoing collaborations and expert analysis to address the evolving pharmaceutical needs of the population.

Exclusive Customer Landscape

The gastrointestinal over-the-counter (otc) drugs market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the gastrointestinal over-the-counter (otc) drugs market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, gastrointestinal over-the-counter (otc) drugs market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Abbott Laboratories
• AbbVie Inc.
• Bausch Health Companies Inc.
• Bayer AG
• Boehringer Ingelheim International GmbH
• Cipla Inc.
• Dr Reddys Laboratories Ltd.
• Eisai Co. Ltd.
• GlaxoSmithKline Plc
• Haleon Plc
• Johnson and Johnson Services Inc.
• Merck KGaA
• Novartis AG
• Pfizer Inc.
• Phathom Pharmaceuticals Inc.
• Prestige Consumer Healthcare Inc.
• Sanofi SA
• SonoScape Medical Corp.
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Vee Excel Drugs And Pharmaceuticals Pvt. Ltd.
• Zoic Pharmaceuticals Pvt. Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

The gastrointestinal over-the-counter (OTC) drug market encompasses a wide range of formulations designed to address various disorders and symptoms related to the digestive system. Indigestion, heartburn, diarrhea, and vomiting are among the common gastrointestinal conditions that OTC drugs cater to. These conditions can significantly impact an individual's quality of life, leading to discomfort, lost productivity, and increased healthcare utilization. Consumer awareness regarding self-medication for gastrointestinal disorders has been on the rise, driven by changing lifestyles and increased health-consciousness. Retail pharmacies and home healthcare settings have become the primary channels for the sale of OTC gastrointestinal drugs. The market dynamics for these products are influenced by several factors, including patient epidemiology, healthcare infrastructure, and the availability of advanced treatments.

Gastroesophageal reflux disease (GERD) and other digestive disorders have become increasingly common due to changing lifestyles and dietary habits. Antacids and other formulations that neutralize stomach acid are popular choices for self-medication. Similarly, probiotic-based drugs have gained popularity due to their natural approach to treating gastrointestinal disorders. The healthcare infrastructure plays a crucial role In the demand for OTC gastrointestinal drugs. Advanced healthcare infrastructure and increased access to healthcare services have led to an increase in the number of hospital visits for gastrointestinal disorders. OTC drugs provide an accessible and cost-effective alternative to prescription drugs for patients seeking relief from mild to moderate symptoms.

The OTC gastrointestinal drug market is also influenced by collaborations between healthcare entities and pharmaceutical companies. These collaborations aim to improve patient care and increase the availability of effective treatments for various gastrointestinal disorders. However, incorrect diagnosis and self-medication can lead to potential risks, including drug interactions and incorrect dosages. The market for OTC gastrointestinal drugs is expected to grow significantly due to the increasing prevalence of gastrointestinal disorders and the rising trend of self-medication. However, factors such as patent expiry, drug abuse, and healthcare infrastructure in developing countries can impact the growth of the market. In conclusion, the gastrointestinal OTC drug market is a dynamic and evolving industry that caters to the growing demand for accessible and effective treatments for various gastrointestinal disorders.

The market is influenced by several factors, including patient epidemiology, healthcare infrastructure, and collaborations between healthcare entities and pharmaceutical companies. As consumer awareness regarding self-medication continues to grow, the market for OTC gastrointestinal drugs is expected to expand significantly.

Request Free Sample

What are the Key Data Covered in this Gastrointestinal Over-The-Counter Drugs Market Research and Growth Report?

• CAGR of the Gastrointestinal OTC Drugs industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the gastrointestinal over-the-counter (otc) drugs market growth of industry companies

We can help! Our analysts can customize this gastrointestinal OTC drugs market research report to meet your requirements.

Get in touch